Fachapotheker/in FPH Spital study materials
Fachapotheker/in FPH Spital study resources

Fachapotheker/in FPH Spital study plan

Fachapotheker/in FPH Spital · Give each week a clear focus.

8 weeks · About 7 hours per week

Week 1

Clinical pharmacy and pharmaceutical care in hospitalized patients (medication reconciliation, drug therapy review, ward rounds) & Pharmacotherapy of major disease states and internal medicine (infectious diseases, cardiology, oncology, intensive care, pediatrics, geriatrics)

  • List the core steps of medication reconciliation at admission, transfer, and discharge, and explain how each step reduces unintended discrepancies.

  • Compare the mechanisms, monitoring parameters, and key adverse effects of the main antibiotic classes used in hospital practice (beta-lactams, glycopeptides, aminoglycosides, fluoroquinolones).

  • Outline the components of a structured drug therapy review (indication, effectiveness, safety, adherence) and apply them to two common internal medicine scenarios (e.g., heart failure, COPD exacerbation).

  • Identify high-risk medications in hospitalized patients and describe at least three specific safety checks for each.

Your checkpoint

A one-page medication reconciliation checklist and a 10-item drug therapy review template, each with brief rationale, ready for use on the ward.

Week 2

Pharmacotherapy of major disease states and internal medicine (infectious diseases, cardiology, oncology, intensive care, pediatrics, geriatrics) & Clinical pharmacology, pharmacokinetics and therapeutic drug monitoring

  • Explain the pathophysiology and first-line pharmacotherapy of acute coronary syndrome, heart failure, and atrial fibrillation, including dosing and monitoring in renal impairment.

  • Describe the principles of antimicrobial stewardship and apply them to choose empiric therapy for common infections (pneumonia, urinary tract infection, sepsis) based on local resistance patterns.

  • Calculate creatinine clearance using Cockcroft-Gault and adjust doses of at least five renally eliminated drugs accordingly.

  • Interpret therapeutic drug monitoring results for vancomycin and aminoglycosides, and recommend dose adjustments based on pharmacokinetic principles.

Your checkpoint

A set of 10 dose-adjustment flashcards for renally eliminated drugs, each showing the calculation and the recommended adjustment, plus a one-page TDM interpretation guide.

Week 3

Pharmacotherapy of major disease states and internal medicine (infectious diseases, cardiology, oncology, intensive care, pediatrics, geriatrics) & Medication safety, pharmacovigilance and risk management (ADRs, medication errors, hygiene, cytotoxic safety)

  • Summarize the mechanisms, monitoring, and management of immune-related adverse events for checkpoint inhibitors and of febrile neutropenia in oncology patients.

  • Describe the pharmacokinetic changes in critically ill patients (altered volume of distribution, augmented renal clearance) and adjust dosing of sedatives and antibiotics accordingly.

  • Explain age-related pharmacokinetic and pharmacodynamic changes and apply them to deprescribing decisions in geriatric patients (e.g., benzodiazepines, anticholinergics).

  • Classify medication errors by stage (prescribing, dispensing, administration) and propose one preventive strategy for each stage.

Your checkpoint

A two-page summary table of high-alert medications in oncology and intensive care, listing monitoring parameters and error-prevention strategies.

Week 4

Drug compounding, sterile and non-sterile preparations, hospital manufacturing and quality assurance (GMP, pharmacopoeia) & Hospital drug logistics and supply chain (procurement, storage, distribution, automated dispensing, narcotics handling)

  • Outline the key requirements of GMP for hospital manufacturing, including cleanroom classification, environmental monitoring, and validation of sterile processes.

  • Describe the principles of non-sterile compounding (weighing, mixing, quality control) and the documentation required for a magistral preparation.

  • Explain the procurement process for hospital drugs, including tender procedures, safety stock calculation, and management of drug shortages.

  • Compare storage requirements for different drug classes (cold chain, narcotics, hazardous drugs) and describe the associated documentation and security measures.

Your checkpoint

A process map for sterile compounding from prescription to release, annotated with critical control points and GMP references.

Week 5

Hospital pharmacy organization, law and professional ethics (incl. Swissmedic, HMG, BetmVV, hospital formulary governance) & Hospital drug logistics and supply chain (procurement, storage, distribution, automated dispensing, narcotics handling)

  • Summarize the Swiss legal framework for hospital pharmacy practice: HMG, BetmVV, Swissmedic requirements for hospital exemptions, and narcotics regulations.

  • Explain the governance of a hospital formulary, including the role of the pharmacy and therapeutics committee and the criteria for drug inclusion.

  • Describe the design and operation of automated dispensing systems and their impact on medication safety and inventory control.

  • Outline the legal and practical requirements for handling narcotics in the hospital, from prescribing to destruction.

Your checkpoint

A one-page flowchart of the hospital formulary decision process, from request to committee decision to implementation, with legal references.

Week 6

Medication safety, pharmacovigilance and risk management (ADRs, medication errors, hygiene, cytotoxic safety) & Clinical pharmacology, pharmacokinetics and therapeutic drug monitoring

  • Explain the pharmacovigilance system in Switzerland, including reporting requirements for ADRs to Swissmedic and the role of the hospital pharmacist.

  • Apply pharmacokinetic principles to interpret plasma concentration-time curves and recommend individualized dosing for a drug with narrow therapeutic index.

  • Describe hygiene measures for preventing healthcare-associated infections, including hand hygiene, isolation precautions, and cleaning of compounding areas.

  • Outline safe handling procedures for cytotoxic drugs at all stages (receipt, preparation, administration, waste) and the associated monitoring of occupational exposure.

Your checkpoint

A one-page ADR reporting checklist and a one-page cytotoxic safe-handling checklist, each with key steps and responsible roles.

Week 7

Research, evidence-based medicine, statistics and scientific communication & Management, leadership, teaching and interprofessional collaboration

  • Critically appraise a randomized controlled trial using a standard checklist (e.g., CONSORT) and interpret the results in the context of clinical practice.

  • Explain basic statistical concepts (p-values, confidence intervals, number needed to treat) and apply them to interpret a published study.

  • Describe strategies for effective interprofessional collaboration on ward rounds and for teaching pharmacy students and junior staff.

  • Outline the principles of change management and leadership in a hospital pharmacy setting, including how to implement a quality improvement project.

Your checkpoint

A one-page critical appraisal of a recent clinical trial relevant to hospital pharmacy practice, including a summary of strengths, limitations, and applicability.

Week 8

Hospital pharmacy organization, law and professional ethics (incl. Swissmedic, HMG, BetmVV, hospital formulary governance) & Clinical pharmacy and pharmaceutical care in hospitalized patients (medication reconciliation, drug therapy review, ward rounds) & Pharmacotherapy of major disease states and internal medicine (infectious diseases, cardiology, oncology, intensive care, pediatrics, geriatrics) & Drug compounding, sterile and non-sterile preparations, hospital manufacturing and quality assurance (GMP, pharmacopoeia) & Hospital drug logistics and supply chain (procurement, storage, distribution, automated dispensing, narcotics handling) & Medication safety, pharmacovigilance and risk management (ADRs, medication errors, hygiene, cytotoxic safety) & Clinical pharmacology, pharmacokinetics and therapeutic drug monitoring & Research, evidence-based medicine, statistics and scientific communication & Management, leadership, teaching and interprofessional collaboration

  • Review all domains using a self-assessment checklist and identify three areas of weakness for further study.

  • Complete a timed mock examination covering all domains and analyze incorrect answers to identify knowledge gaps.

  • Integrate learning from all domains by solving two complex case scenarios that require medication reconciliation, therapeutic drug monitoring, and legal considerations.

  • Create a personal continuing education plan for the next six months, targeting the identified weaknesses.

Your checkpoint

A completed self-assessment checklist with a prioritized list of three knowledge gaps and a six-month continuing education plan.

Milestones

Week 2: Can explain and apply medication reconciliation and drug therapy review in two clinical scenarios, and correctly adjust doses for renal impairment in five cases.

Week 4: Can describe GMP requirements for sterile compounding and the hospital drug procurement process, and has produced a process map with critical control points.

Week 6: Can explain pharmacovigilance reporting and cytotoxic safe handling, and interpret TDM results to recommend individualized dosing.

Week 8: Achieved at least 70% on the mock examination and completed a self-assessment with a continuing education plan.